The value of laser therapy in BPH
Our laser therapy portfolio has the ability to deliver benefits to your patients in three key areas:
1.
Durable efficacy
2.
Technological advancements
3.
Patient satisfaction
Durable efficacy
In the long term, PVP therapy has also been shown to maintain its efficacy. Prostate-specific antigen (PSA) level has been shown to decrease significantly with levels falling by 56% (2.0 ng/mL) at 3 months and a further 2.6 ng/mL reduction at 57 months.5
In addition, PVP with the GreenLight XPS is an effective technique able to durably improve reported clinical outcomes in patients with benign prostatic enlargement (BPE).5
Technological advancements
At Boston Scientific, we continue to improve and develop our laser treatment portfolio. The GreenLight XPS Laser Therapy System has advanced technical specifications compared to previous devices, with a maximum power of 180 W and an improved beam geometry of the MoXyTM fiber.8
Patient satisfaction
Learn more about our laser portfolio
